Chronic Kidney Disease in the Management of people with Type 2 Diabetes in General Practice

Lead Researcher Email Number Webpage
Dr Jo-Anne Manski-Nankervis +61 3 9035 8019 View page

Project Details

Rationale for research

General practice plays a key role in the prevention and management of chronic kidney disease (CKD), a common complication of type 2 diabetes. Previous studies have shown that screening (using blood and urine tests) and recording (in the patients medical record) of CKD in general practice is sub-optimal. This may have significant implications for safe prescribing of medications, because when kidney function is impaired, different medications or different doses of medicines may need to be used in order to prevent deterioration of kidney function and to avoid adverse medication events.


  1. To explore the current screening, prevalence, recording and management of CKD among people with type 2 diabetes;
  2. Explore whether prescribing patterns of medicines that reduce blood glucose levels (antihyperglycaemic medications) and cardiovascular medications in general practice are appropriate and safe for people with T2D who have CKD.

Study Design

Descriptive study


Australian general practice


102,000 people with type 2 diabetes attending general practices participating in the NPS Medicine Insight program

When final results will be reported/timeline/are preliminary results available:

Final reporting will be available 2017



  • Associate Professor Simon Bell, Centre for Medicine Use and Safety,  Monash University


Shepherd Foundation

Research Group

Diabetes and Cardio-Metabolic Conditions

Faculty Research Themes

Infection and Immunology

School Research Themes

Cardiometabolic , Integrated Critical Medicine

Key Contact

For further information about this research, please contact the research group leader.

Department / Centre

General Practice

Unit / Centre

Diabetes and Cardio-Metabolic Conditions